Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - CA
$ 2.04
2 %
$ 786 M
Market Cap
14.57
P/E
1. INTRINSIC VALUE
Balance Sheet
Cronos Group Inc.
| Current Assets | 936 M |
| Cash & Short-Term Investments | 859 M |
| Receivables | 29.8 M |
| Other Current Assets | 47.6 M |
| Non-Current Assets | 230 M |
| Long-Term Investments | 2.81 M |
| PP&E | 135 M |
| Other Non-Current Assets | 92.8 M |
| Current Liabilities | 49.7 M |
| Accounts Payable | 17 M |
| Short-Term Debt | 1.02 M |
| Other Current Liabilities | 31.7 M |
| Non-Current Liabilities | 5.63 M |
| Long-Term Debt | 993 K |
| Other Non-Current Liabilities | 4.64 M |
EFFICIENCY
Earnings Waterfall
Cronos Group Inc.
| Revenue | 118 M |
| Cost Of Revenue | 92.4 M |
| Gross Profit | 25.2 M |
| Operating Expenses | 102 M |
| Operating Income | -76.5 M |
| Other Expenses | -117 M |
| Net Income | 40 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Cronos Group Inc.
| Net Income | 40 M |
| Depreciation & Amortization | 9.34 M |
| Capital Expenditures | -13.2 M |
| Stock-Based Compensation | 8.7 M |
| Change in Working Capital | -311 K |
| Others | -36.1 M |
| Free Cash Flow | 6.43 M |
Wall Street Analysts Price Targets
Cronos Group Inc.
Wall Street analysts predict an average 1-year price target for CRON of $3.15 , with forecasts ranging from
a
low of
$2.3 to a high of $4.5 .
CRON Lowest Price Target
Wall Street Target
2.3 USD
12.75%
CRON Average Price Target
Wall Street Target
3.15 USD
54.41%
CRON Highest Price Target
Wall Street Target
4.5 USD
120.59%
4. DIVIDEND
ANALYSIS
CRON does not distribute dividends.
5. COMPETITION
6. Ownership
Insider Ownership
Cronos Group Inc.
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Americans Should Buy Canadian Cannabis Companies
Canadian LPs offer compelling risk/reward versus U.S. cannabis stocks, with stronger balance sheets, tangible book value, and global opportunities due to federal legality. Despite recent rallies, Canadian LPs remain cheap on enterprise value to EBITDA, especially Village Farms, Organigram, and Tilray Brands, which I hold in my model portfolio. U.S. MSOs face significant risks from 280E tax liabilities and negative tangible equity, making Canadian LPs a safer bet for cannabis investors right now.
seekingalpha.com
- 1 week ago
New Strong Buy Stocks for July 3rd
CRON, CDE, SOUHY, PRM and STNG have been added to the Zacks Rank #1 (Strong Buy) List on July 3, 2025.
zacks.com
- 2 weeks ago
Cronos Grows its International Footprint in Switzerland
TORONTO, July 02, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) announced today that it is expanding distribution with its PEACE NATURALS® medical cannabis brand in the Swiss market through its partnership with Dascoli Pharma AG (“Dascoli”), a Swiss-based company specializing in the supply and distribution of medical cannabis and healthcare training.
globenewswire.com
- 2 weeks ago
Cronos Group Inc. Announces Results of 2025 Annual Meeting of Shareholders
TORONTO, June 23, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) today announced that at its Annual Meeting of Shareholders held on Friday, June 20, 2025 (the “Meeting”), shareholders holding a total of 276,989,452 common shares of the Company voted in person or by proxy, representing 71.87% of the total number of common shares of the Company outstanding.
globenewswire.com
- 3 weeks ago
3 Cannabis Stocks For Investors To Secure For Future Gains
The current state of the cannabis sector has people feeling a type of way. To be more descriptive, those who are invested in marijuana stocks are feeling the backlash of the market. For some time, there has been a sharp decline in the overall trading for most top marijuana stocks. Now, you would think that with the sector down and showing no true signs of recovery, all is lost. That is not the case, as most companies are making money and having a positive impact.
marijuanastocks.com
- 4 weeks ago
3 Marijuana Stocks For Longterm Investors
The volatile downtrend for marijuana stocks has been both bitter and sweet. On the one hand, you have the sector trading at all-time lows. The upside to this is being able to pick up shares at a cheap price. But the sector is not as active as it once was and outside of politics, it's been challenging to find a catalyst for the sector to bounce. Nonetheless, the sweeter part is knowing that the cannabis industry becoming more successful.
marijuanastocks.com
- 1 month ago
3 Recession-Resistant Dividend Kings With High Yields
Key Points Dividend Kings are some of the most stable stocks in the market. Their dividends have been hiked through recessions, and the trend is likely to continue. These three pay high yields and are also resistant to recessions. Are you ahead, or behind on retirement? SmartAsset’s free tool can match you with a financial advisor in minutes to help you answer that today. Each advisor has been carefully vetted, and must act in your best interests. Don’t waste another minute; get started by clicking here.(Sponsor) Dividend Kings are some of the most solid stocks to own in the market. The title means that the company has raised its dividends for the past 50 years straight. This is not a title that any company wants to forgo, so the dividends that Dividend Kings pay are the most stable in the market. Moreover, getting that title in the first place means that these companies would have to have very stable businesses. And they do. Dividend Kings are usually consumer staples, utilities, or are in sectors that are very defensive in nature. This also helps them weather recessions well.Here are three to look into that come with high yields. These yields may not look as high due to Treasury yields, but they’re among the best you’ll get when it comes to Dividend Kings. And the underlying stock also appreciates, unlike Treasuries. Altria Group (MO) Altria Group (NYSE:MO) is a tobacco company. And as you’d expect, this company has very sticky cash flows regardless of the economic environment. Even a recession is not going to change people’s smoking habits overnight. If anything, it’ll cause an increase in smoking rates. One of the biggest arguments for not investing in MO stock is that smoking rates are seeing a gradual decline, especially among the youth. But the notion that young people do not smoke is wrong. It is true they don’t do traditional cigarettes as much, but electronic cigarettes (or vapes) and other alternative products are still popular. Altria is far from dying. It is now betting on e-vapor and nicotine pouches. Regardless, the main business is still on a gradual slope downwards, as even vapes are becoming less popular. People are still buying MO stock as it has an 8% stake in Anheuser-Busch InBev (NYSE:BUD) for global beer exposure, and a 41% stake in Cronos Group (NASDAQ:CRON) for cannabis exposure. On top of that, Altria is considered a premium brand company, and its portfolio is almost exclusively made up of Marlboro. People are willing to pay more for it, and Altria has been using that pricing power to keep its cash flow (and dividends) steady. It’ll take multiple decades for the cash flow to fall markedly. In the meantime, I’d sit on this recession-resistant dividend stock with solid yields. MO stock comes with a dividend yield of 6.88% and 56 years of consecutive dividend hikes. PepsiCo (PEP) PepsiCo (NASDAQ:PEP) is one of the safest stocks in the market right now. The company’s products have solid demand as it dominates snack shelves. Moreover, the valuation is much better now. It trades at just 19 times earnings after a 26.4% decline from its peak, though PEP stock has traded sideways through May. The recent decline is worse than 2008 or 2020 in terms of value and is quite comparable to the pandemic crash in percentage terms. Even if a recession were to hit, I see little downside risk from here, but plenty of long-term upside. This is a well-established company that should recover from the selloff just fine and deliver solid returns in the coming years. In the meantime, you could sit on its 4.31% dividend yield with 54 years of consecutive dividend increases. Historically, Wall Street has paid over 26 times earnings for PEP stock, and even though the growth outlook going forward is not as good as its growth from 2019 to 2023, you should keep in mind that PepsiCo had declining revenue for a good stretch of the early 2010s and still kept an upward trajectory due to the bottom line being resilient. Once interest rate cuts start, that should be the catalyst that finally nudges PepsiCo higher toward its historical trajectory. It posted a net interest loss of $264 million, and if it can receive some relief on that front, along with organic revenue growth turning a corner, Wall Street would have no option but to turn bullish. Northwest Natural Holding (NWN) Northwest Natural Holdings (NYSE:NWN) is a natural gas utility company. Utility stocks are one of the safest names you can invest in due to tariffs making the broader industry more volatile. Utility companies do their business almost entirely domestically, and they don’t have much exposure to trade policy. These companies are also detached from natural gas prices, since their main business is natural gas distribution through pipelines. Northwest Natural also does wastewater management and energy storage. NWN stock is now down over 48% from its highs in 2019. The stock mainly declined due to inflation and rate hikes increasing debt servicing costs. However, most of the bearishness was priced in by late 2023, and the stock has been on an uptrend since. The economic cycle is turning with more rate cuts on the horizon, so more upside is likely in the coming years. In the meantime, you can sit on its 4.93% dividend yield, which has been raised for 70 consecutive years. The dividend payout ratio of 65% is quite good for a utility business.The post 3 Recession-Resistant Dividend Kings With High Yields appeared first on 24/7 Wall St..
https://247wallst.com
- 1 month ago
Marijuana Stocks To Watch With Strong Market Potential
At one time the hype on various cannabis stocks was enough to send the market into an upward frenzy. Now not so much however the perspective on the cannabis sector has changed. A once short-term way to make gains is now looking like a promising long-term investment. There is still a large amount of uncertainty and even more with Donald Trump in office. It has been the success of the legal market that has kept people looking for marijuana stocks to buy.
marijuanastocks.com
- 1 month ago
Cronos Group Inc. to Speak at the TD Cowen 9th Annual Future of the Consumer Conference
TORONTO, June 02, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and CEO, will speak at the TD Cowen 9th Annual Future of the Consumer Conference on Wednesday, June 4, 2025, at 3:30 p.m. EST.
globenewswire.com
- 1 month ago
Cronos Group: Industry Fortress Balance Sheet And FCF Create A Solid Upside Potential
Cronos Group boasts a strong net cash position nearly equal to its market cap, offering downside protection and operational flexibility. Leading brands like Spinach and Lord Jones have secured top market shares in key cannabis segments, driving consistent revenue growth. The company has achieved free cash flow positivity, signaling the end of its capital-intensive phase and disciplined capital allocation.
seekingalpha.com
- 1 month ago
Top Marijuana Stocks In A Volatile Market
Right now, cannabis companies are still reporting Q1 2025 earnings, and for most things, are looking good. It is undeniable how well the cannabis industry is doing, even as the road ahead is still a tough one. Profits are being made and growth is occurring throughout the sector.
marijuanastocks.com
- 1 month ago
Cronos Reports Improved Financials For Q1-2025 As Demand Outpaces Supply
Cronos recently reported improved financial performance for Q1-2025. International sales have increased and domestic sales are outpacing supply. The company has a new risk with tariffs in the Israeli medical market.
seekingalpha.com
- 2 months ago
8. Profile
Summary
Cronos Group Inc. CRON
COUNTRY
CA
INDUSTRY
Drug Manufacturers - Specialty & Generic
MARKET CAP
$ 786 M
Dividend Yield
0.00%
Description
Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. It also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.
Contact
111 Peter Street, Stayner, ON, M5V 2H1
https://www.thecronosgroup.com
IPO
Date
Feb. 27, 2018
Employees
459
Officers
Mr. Adam Wagner
Senior Vice President & Head of Cronos Israel
Mr. James Holm
Executive Officer
Mr. James Andrew McGinness III
Vice President, Controller & Principal Accounting Officer
Mr. Michael Ryan Gorenstein J.D.
President, Chief Executive Officer & Chairman
Ms. Anna Shlimak
Chief Financial Officer
Mr. Arye Weigensberg
Senior Vice President and Head of Research & Development
Mr. Jeffrey David Jacobson
Chief Growth Officer
Mr. Terry Gregory-Joseph Doucet
General Counsel & Corporate Secretary
Ms. Shannon Buggy
Senior Vice President & Global Head of People